OTC:ZVSA | Profit Breakdown | ZyVersa Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-06-30 to 2026-03-31
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-03-31-$1.3M-$1.79M
2025-12-31-$551,858.00-$678,572.00-$678,572.00
2025-09-30-$20.75M-$20.66M-$19.81M
2025-06-30-$2.04M-$2.21M-$2.21M
2025-03-31-$2.14M-$2.26M
2024-12-31-$1.29M-$1.42M-$1.42M
2024-09-30-$2.27M-$2.4M-$2.4M
2024-06-30-$2.75M-$2.75M-$2.76M
2024-03-31-$2.83M-$2.83M-$2.83M
2023-12-31-$13.93M-$13.93M-$13.34M
2023-09-30-$2.9M-$2.9M-$2.9M
2023-06-30-$86.33M-$86.33M-$78.51M
2023-03-31-$4.59M-$4.59M-$3.54M
2022-12-12-$10.73M-$12.25M
2022-09-30-$985,605.00-$679,087.00
2022-06-30-$498,752.00-$393,639.00
2022-03-31-$801,048.00-$720,006.00
2021-09-30-$174.00-$174.00
2021-06-30-$1,895.00-$789.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$25.49M-$25.8M-$24.95M
2024-12-31-$9.14M-$9.41M-$9.41M
2023-12-31-$107.75M-$107.75M-$98.3M
2022-12-12-$13.01M-$14.05M-$14.05M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.